Tandem Native Mass-Spectrometry on Antibody-Drug Conjugates and Submillion Da Antibody-Antigen Protein Assemblies on an Orbitrap EMR Equipped with a High-Mass Quadrupole Mass Selector.

Native mass spectrometry is emerging as a powerful tool for the characterization of intact antibodies and antibody-based therapeutics. Here, we demonstrate new possibilities provided by the implementation of a high mass quadrupole mass selector on the recently introduced Orbitrap Exactive EMR mass spectrometer. This configuration allows precursor ion selection, and thus tandem mass spectrometry experiments, even on analytes with masses in the hundreds of kilodaltons. We apply tandem mass spectrometry to localize the drug molecules in the therapeutic antibody-drug conjugate brentuximab vedotin, which displays a heterogeneous drug load. Our tandem MS data reveal that drug conjugation takes place nonhomogeneously to cysteine residues both on the light and heavy chains. Next, we analyzed how many antigens bind to IgG hexamers, based on a recently described antibody mutant IgG1-RGY that forms hexamers and activates complement in solution. The fully saturated IgG1-RGY-antigen complexes displayed a stoichiometry of IgG:CD38 of 6:12, possessing a molecular weight of about 1.26 MDa and demonstrating that IgG assembly does not hamper antigen binding. Through tandem MS experiments, we retrieve information about the spatial arrangement and stoichiometry of the subunits within this complex. These examples underscore the potential of this further modified Orbitrap-EMR instrument especially for the in-depth characterization by native tandem mass spectrometry of antibodies and antibody-based constructs.

[1]  J. Shabanowitz,et al.  Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Albert J R Heck,et al.  Investigation of intact protein complexes by mass spectrometry. , 2004, Mass spectrometry reviews.

[3]  M. Sliwkowski,et al.  Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates , 2012, Nature Biotechnology.

[4]  S. Alley,et al.  Analytical and bioanalytical technologies for characterizing antibody-drug conjugates. , 2013, Current opinion in chemical biology.

[5]  J. Reichert,et al.  Antibody-drug conjugates , 2013, mAbs.

[6]  Natalie J. Thompson,et al.  Exploring an orbitrap analyzer for the characterization of intact antibodies by native mass spectrometry. , 2012, Angewandte Chemie.

[7]  Damon L. Meyer,et al.  Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate , 2004, Clinical Cancer Research.

[8]  John F. Valliere-Douglass,et al.  Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry. , 2015, Molecular pharmaceutics.

[9]  P. Cramer,et al.  Structural biology of RNA polymerase III: mass spectrometry elucidates subcomplex architecture. , 2007, Structure.

[10]  Jared B Shaw,et al.  Complete protein characterization using top-down mass spectrometry and ultraviolet photodissociation. , 2013, Journal of the American Chemical Society.

[11]  Christian Bailly,et al.  The next generation of antibody-drug conjugates comes of age. , 2010, Discovery medicine.

[12]  Alain Van Dorsselaer,et al.  Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment. , 2014, Analytical chemistry.

[13]  P. Parren,et al.  In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap , 2013, mAbs.

[14]  Aditya A Wakankar,et al.  Analytical methods for physicochemical characterization of antibody drug conjugates , 2011, mAbs.

[15]  W. J. Galush,et al.  Profiling antibody drug conjugate positional isomers: a system-of-equations approach. , 2012, Analytical chemistry.

[16]  G. Vidarsson,et al.  Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange , 2014, The Journal of Biological Chemistry.

[17]  Mohammed Shameem,et al.  Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications , 2014, mAbs.

[18]  W. Roos,et al.  Probing the biophysical interplay between a viral genome and its capsid. , 2013, Nature chemistry.

[19]  John F. Valliere-Douglass,et al.  Native intact mass determination of antibodies conjugated with monomethyl Auristatin E and F at interchain cysteine residues. , 2012, Analytical chemistry.

[20]  A. Heck,et al.  Analytical approaches for size and mass analysis of large protein assemblies. , 2014, Annual review of analytical chemistry.

[21]  François Debaene,et al.  Time resolved native ion-mobility mass spectrometry to monitor dynamics of IgG4 Fab arm exchange and "bispecific" monoclonal antibody formation. , 2013, Analytical chemistry.

[22]  A. Beck,et al.  Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysis. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[23]  Albert J R Heck,et al.  High-sensitivity Orbitrap mass analysis of intact macromolecular assemblies , 2012, Nature Methods.

[24]  C. Robinson,et al.  Analysis of the subunit organization of the eIF2B complex reveals new insights into its structure and regulation , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  Kenneth C. Anderson,et al.  Daratumumab, a Novel Therapeutic Human CD38 Monoclonal Antibody, Induces Killing of Multiple Myeloma and Other Hematological Tumors , 2011, The Journal of Immunology.

[26]  A. Heck,et al.  Defining the Stoichiometry and Cargo Load of Viral and Bacterial Nanoparticles by Orbitrap Mass Spectrometry , 2014, Journal of the American Chemical Society.

[27]  Piet Gros,et al.  Complement Is Activated by IgG Hexamers Assembled at the Cell Surface , 2014, Science.

[28]  Paul Polakis,et al.  Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index , 2008, Nature Biotechnology.

[29]  A. Younes,et al.  Brentuximab Vedotin (SGN-35) , 2011, Clinical Cancer Research.

[30]  R. Chari,et al.  Antibody-drug conjugates: an emerging concept in cancer therapy. , 2014, Angewandte Chemie.

[31]  John F. Valliere-Douglass,et al.  Measurement of in vivo drug load distribution of cysteine-linked antibody-drug conjugates using microscale liquid chromatography mass spectrometry. , 2014, Analytical chemistry.

[32]  A. Heck,et al.  Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry , 2014, Nature Protocols.

[33]  N. Kelleher,et al.  From protein complexes to subunit backbone fragments: a multi-stage approach to native mass spectrometry. , 2013, Analytical chemistry.

[34]  Peter G Schultz,et al.  Synthesis of site-specific antibody-drug conjugates using unnatural amino acids , 2012, Proceedings of the National Academy of Sciences.

[35]  M. B. Denton,et al.  The quadrupole mass filter: Basic operating concepts , 1986 .

[36]  John F. Valliere-Douglass,et al.  Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry. , 2014, Analytical chemistry.

[37]  M. Dorywalska,et al.  Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates. , 2013, Chemistry & biology.

[38]  S. Sanglier-Cianférani,et al.  Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS. , 2009, Analytical chemistry.

[39]  S. Bhakta,et al.  Engineering THIOMABs for site-specific conjugation of thiol-reactive linkers. , 2013, Methods in molecular biology.

[40]  P. Parren,et al.  Quantitative analysis of the interaction strength and dynamics of human IgG4 half molecules by native mass spectrometry. , 2011, Structure.

[41]  Natalie J. Thompson,et al.  Complex mixtures of antibodies generated from a single production qualitatively and quantitatively evaluated by native Orbitrap mass spectrometry , 2014, mAbs.

[42]  J. Queiroz,et al.  Hydrophobic interaction chromatography of proteins. , 2001, Journal of biotechnology.

[43]  Hongcheng Liu,et al.  Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC-MS analysis. , 2010, Analytical chemistry.